References
- 1Elamin S, Abu-Aisha H. Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: review of current international recommendations. Arab J Nephrol Transp. 2011; 4:35-47.ElaminSAbu-AishaHPrevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers:review of current international recommendationsArab J Nephrol Transp201143547
- 2Fabrizi F, Takkouche B, Lunghi G, Dixit V, Messa P, Martin P. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat. 2007; 14:697-703.17875004FabriziFTakkoucheBLunghiGDixitVMessaPMartinPThe impact of hepatitis C virus infection on survival in dialysis patients:meta-analysis of observational studiesJ Viral Hepat200714697703
- 3Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Meta-analysis: effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther. 2004; 20:1271-7.1560638810.1111/j.1365-2036.2004.02290.xFabriziFMartinPDixitVBunnapradistSDulaiGMeta-analysis:effect of hepatitis C virus infection on mortality in dialysisAliment Pharmacol Ther20042012717
- 4Saha D, Agarwal SK. Hepatitis and HIV infection during haemodialysis. J Indian Med Assoc. 2001; 99: 194-9.11666025SahaDAgarwalSKHepatitis and HIV infection during haemodialysisJ Indian Med Assoc2001991949
- 5Reddy GA, Dakshinamurmuthy KV, Neelaprasad P, Gangadhar T, Lakshmi V. Prevalence of HBV and HCV dual infection in patients on haemodialysis. Indian J Med Microbiol. 2005; 23:41-3.10.4103/0255-0857.1387215928421ReddyGADakshinamurmuthyKVNeelaprasadPGangadharTLakshmiVPrevalence of HBV and HCV dual infection in patients on haemodialysisIndian J Med Microbiol200523413
- 6Fabrizi F, Martin P, Dixit V, Kanwal F, Dulai G. HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant. 2005; 5:2913-21.1630300510.1111/j.1600-6143.2005.01113.xFabriziFMartinPDixitVKanwalFDulaiGHBsAg seropositive status and survival after renal transplantation:meta-analysis of observational studiesAm J Transplant20055291321
- 7Favero MS, Maynard JE, Petersen NJ, Boyer KM, Bond WW, Berquist KR, et al. Hepatitis B antigen on environmental surfaces. Lancet. 1973; 2:1455.4128776FaveroMSMaynardJEPetersenNJBoyerKMBondWWBerquistKRet alHepatitis B antigen on environmental surfacesLancet197321455
- 8Center for Diseases Control and Prevention. Recommendations for preventing transmission of infections among chronic HD patients. MMWR Recomm Rep. 2001; 50:1-43.Center for Diseases Control and Prevention. Recommendations for preventing transmission of infections among chronic HD patientsMMWR Recomm Rep200150143
- 9Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11:97-107.1499634310.1046/j.1365-2893.2003.00487.xLavanchyDHepatitis B virus epidemiology disease burden treatment and current and emerging prevention and control measuresJ Viral Hepat20041197107
- 10Ribot S, Rothstein M, Goldblat M, Grasso M. Duration of hepatitis B surface antigenemia (HBsAg) in hemodialysis patients. Arch Intern Med. 1979; 139: 178-80.10.1001/archinte.1979.03630390036015434972RibotSRothsteinMGoldblatMGrassoMDuration of hepatitis B surface antigenemia (HBsAg) in hemodialysis patientsArch Intern Med197913917880
- 11Johnson DW, Dent H, Yao Q, Tranaeus A, Huang CC, Han DS, et al. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant. 2009; 24: 1598-603.1909608310.1093/ndt/gfn684JohnsonDWDentHYaoQTranaeusAHuangCCHanDSet alFrequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries:analysis of registry dataNephrol Dial Transplant2009241598603
- 12Alter MJ, Favero MS, Maynard JE. Impact of infection control strategies on the incidence of dialysisassociated hepatitis in the United States. J Infect Dis. 1986; 153:1149-51.370112010.1093/infdis/153.6.1149AlterMJFaveroMSMaynardJEImpact of infection control strategies on the incidence of dialysisassociated hepatitis in the United StatesJ Infect Dis1986153114951
- 13Chan TM. Hepatitis B virus and dialysis patients. Up to Date. [online] 2016. [cited 2015 August 14]. Available from: http://www.uptodate.com/contents/hepatitisb-virus-and-dialysis-patientsChanTMHepatitis B virus and dialysis patientsUp to Date. [online] 2016cited
2015Aug14 Available fromhttp://www.uptodate.com/contents/hepatitisb-virus-and-dialysis-patients - 14Miller ER, Alter MJ, Tokars JI. Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis. 1999; 33:356.1002365010.1016/S0272-6386(99)70312-4MillerERAlterMJTokarsJIProtective effect of hepatitis B vaccine in chronic hemodialysis patientsAm J Kidney Dis199933356
- 15Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis. 2000; 20:17-35.10.1055/s-2000-9505AlterHJSeeffLBRecovery, persistence, and sequelae in hepatitis C virus infection:a perspective on long-term outcomeSemin Liver Dis2000201735
- 16Kidney Disease Improving Global Outcomes (KDIGO). KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease. Kidney Int Suppl. 2008; 109: 1-99.Kidney Disease Improving Global Outcomes (KDIGO). KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney diseaseKidney Int Suppl2008109199
- 17Fissell RB, Bragg-Gresham JL, Woods JD. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int. 2004; 65:2335-42.10.1111/j.1523-1755.2004.00649.xFissellRBBragg-GreshamJLWoodsJDPatterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents:The DOPPSKidney Int200465233542
- 18Petrosillo N, Gilli P, Serraino D, Dentico P, Mele A, Ragni P, et al. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis. 2001; 37: 1004-10.1132568310.1016/S0272-6386(05)80017-4PetrosilloNGilliPSerrainoDDenticoPMeleARagniPet alPrevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysisAm J Kidney Dis200137100410
- 19Shebeb AM, Kotkat AM, Abd El Reheim SM, Farghaly AG, Fetohy EM. An intervention study for prevention of HCV infection in some hemodialysis units in Alexandria. J Egypt Public Health Assoc. 2006; 81:119-41.17382087ShebebAMKotkatAMAbd El ReheimSMFarghalyAGFetohyEMAn intervention study for prevention of HCV infection in some hemodialysis units in AlexandriaJ Egypt Public Health Assoc20068111941
- 20Gallego E, Lopez A, Perez J, Llamas F, Lorenzo I, Lopez E, et al. Effect of isolation measures on the incidence and prevalence of Hepatitis C virus infection in hemodialysis. Nephron Clin Pract. 2006; 104:c1-6.10.1159/000093252GallegoELopezAPerezJLlamasFLorenzoILopezEet alEffect of isolation measures on the incidence and prevalence of Hepatitis C virus infection in hemodialysisNephron Clin Pract200610416
- 21Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int. 2008; 12:378-82.1863809610.1111/j.1542-4758.2008.00284.xAlavianSMBagheri-LankaraniKMahdavi-MazdehMNouroziSHepatitis B and C in dialysis units in Iran:changing the epidemiologyHemodial Int20081237882
- 22Agarwal SK, Dash SC, Gupta S, Pandey RM. Hepatitis C virus infection in haemodialysis: the ‘no-isolation’ policy should not be generalized. Nephron Clin Pract. 2009; 111:133-40.10.1159/000191208AgarwalSKDashSCGuptaSPandeyRMHepatitis C virus infection in haemodialysis:the ‘no-isolation’ policy should not be generalizedNephron Clin Pract200911113340
- 23Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, et al. for the German Acute Hepatitis C Therapy Group. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med. 2001; 345:1452-7.JaeckelECornbergMWedemeyerHSantantonioTMayerJZankelMet alfor the German Acute Hepatitis C Therapy GroupTreatment of acute hepatitis C with interferon alfa-2b. N Engl J Med200134514527
- 24Tasyaran MA. [Epidemiology of HBV infection]. In: Kilicturgay K, Badur S, editors. [Viral hepatitis]. Istanbul; Deniz Press; 2001. p. 121-8. [In Turkish]TasyaranMA
[Epidemiology of HBV infection] KilicturgayKBadurS[Viral hepatitis]IstanbulDeniz Press20011218[In Turkish] - 25Ozsoy MF, Emekdas G, Pasha A. [Seroprevalence of Hepatitis B and Hepatitis C in healthcare personnel]. Viral Hepatitis Journal. 2000; 2:71-4. [In Turkish].OzsoyMFEmekdasGPashaA[Seroprevalence of Hepatitis B and Hepatitis C in healthcare personnel]Viral Hepatitis Journal20002714[In Turkish]
- 26Fabrizi F, Messa P, Martin P. Hepatitis B virus infection and the dialysis patient. Semin Dial. 2008; 21:440-6.1839720210.1111/j.1525-139X.2008.00437.xFabriziFMessaPMartinPHepatitis B virus infection and the dialysis patientSemin Dial2008214406
- 27Erek E, Suleymanlar G, Serdengecti K. National hemodialysis, transplantation and nephrology registry report of Turkey, 2006. Turkish Nephrology Society. Istanbul: Pasifik Press; 2007.ErekESuleymanlarGSerdengectiK
National hemodialysis, transplantation and nephrology registry report of Turkey, 2006 Turkish Nephrology SocietyIstanbulPasifik Press2007 - 28Suleymanlar G, Altiparmak MR, Seyahi N. National hemodialysis, transplantation and nephrology registry report of Turkey, 2011. Turkish Nephrology Society. Istanbul: Pasifik Press; 2012.SuleymanlarGAltiparmakMRSeyahiN
National hemodialysis, transplantation and nephrology registry report of Turkey, 2011 Turkish Nephrology SocietyIstanbulPasifik Press2012 - 29Daglar D, Ergani A, Demirbakan H, Ozhak Baysan B, Ongut G, Ogunc D, et al. [Investigation of Hepatitis B and Hepatitis C virus infections by serological and molecular methods in hemodialysis patients.] Mikrobiyol Bul. 2014; 48:143-50. [Article in Turkish, English abstract]DaglarDErganiADemirbakanHOzhak BaysanBOngutGOguncDet al[Investigation of Hepatitis B and Hepatitis C virus infections by serological and molecular methods in hemodialysis patients.] Mikrobiyol Bul20144814350[Article in Turkish English abstract]
- 30Official Gazette of the Republic of Turkey. [Regulation on dialysis centers]. [online] 2014. [cited 2016 July 30]. Available from: http://www.resmigazete.gov.tr/eskiler/2005/05/20050508-5.htm [in Turkish]Official Gazette of the Republic of Turkey[Regulation on dialysis centers]. [online] 2014cited
2016July30 Available fromhttp://www.resmigazete.gov.tr/eskiler/2005/05/20050508-5.htm[in Turkish] - 31Agarwal SK. Hemodialysis of patients with HCV infection: isolation has a definite role. Nephron Clin Pract. 2011; 117:328-32.AgarwalSKHemodialysis of patients with HCV infection:isolation has a definite roleNephron Clin Pract201111732832
- 32Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis. 2000; 20:1-16.1089542810.1055/s-2000-9506WasleyAAlterMJEpidemiology of hepatitis C:geographic differences and temporal trendsSemin Liver Dis200020116
- 33Kaygusuz S. [Chronic renal failure and viral hepatitis]. Klimik J. 2004; 17:72-81. [In Turkish]KaygusuzS[Chronic renal failure and viral hepatitis]. Klimik J2004177281[In Turkish]
- 34Erek E, Serdengecti K, Suleymanlar G. National hemodialysis, transplantation and nephrology registry report of Turkey, 2004. Turkish Nephrology Society. Istanbul: Art Press; 2005.ErekESerdengectiKSuleymanlarG
National hemodialysis transplantation and nephrology registry report of Turkey 2004 Turkish Nephrology SocietyIstanbulArt Press2005 - 35Sirmatel F, Sirmatel O, Usalan C, Barlioglu C, Goymen A, Kepekci E, et al. [The seroprevalence of hepatitis B and hepatitis C in hemodialysis patients.] Turkish J Infect. 2008; 22:23-8. [In Turkish]SirmatelFSirmatelOUsalanCBarliogluCGoymenAKepekciEet al[The seroprevalence of hepatitis B and hepatitis C in hemodialysis patients.] Turkish J Infect200822238[In Turkish]
- 36Zahedi MJ, Moghaddam SD, Alavian SM, Dalili M. Seroprevalence of hepatitis viruses B, C, D and HIV infection among hemodialysis patients in Kerman province, South-East Iran. Hepat Mon. 2012; 12: 339-43.10.5812/hepatmon.5969ZahediMJMoghaddamSDAlavianSMDaliliMSeroprevalence of hepatitis viruses B C D and HIV infection among hemodialysis patients in Kerman province South-East IranHepat Mon20121233943
- 37Chang JM, Huang CF, Chen SC, Dai CY, Yeh ML, Huang JF, et al. Discrepancy between serological and virological analysis of viral hepatitis in hemodialysis patients. Int J Med Sci. 2014; 11:436-41.2468830510.7150/ijms.8265ChangJMHuangCFChenSCDaiCYYehMLHuangJFet alDiscrepancy between serological and virological analysis of viral hepatitis in hemodialysis patientsInt J Med Sci20141143641